Sensus Healthcare(SRTS)

Search documents
Sensus Healthcare(SRTS) - 2021 Q4 - Annual Report
2022-03-25 20:03
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE FISCAL YEAR ENDED DECEMBER 31, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM ____________ TO ____________ Commission File Number: 001-37714 Sensus Healthcare, Inc. (Exact name of registrant as specified in its charter) | Delaware | 27-1647271 | | --- ...
Sensus Healthcare(SRTS) - 2021 Q4 - Earnings Call Transcript
2022-02-11 03:14
Sensus Healthcare, Inc. (NASDAQ:SRTS) Q4 2021 Results Conference Call February 10, 2022 4:30 PM ET Company Participants Kim Golodetz - Investor Relations, LHA Joe Sardano - Chief Executive Officer Javier Rampolla - Chief Financial Officer Michael Sardano - President and General Counsel Conference Call Participants Alex Nowak - Craig-Hallum Capital Anthony Vendetti - Maxim Group Yi Chen - H.C. Wainwright Ben Haynor - Alliance Global Partners Operator Good day, and welcome to your Sensus Healthcare 4Q 2021 Ea ...
Sensus Healthcare(SRTS) - 2021 Q3 - Quarterly Report
2021-11-10 19:23
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ____________ to ____________ Commission File Number: 001-37714 Sensus Healthcare, Inc. (Exact name of registrant as specified in its charter) | Delaware | 27-1647271 ...
Sensus Healthcare(SRTS) - 2021 Q3 - Earnings Call Transcript
2021-11-07 04:58
Sensus Healthcare, Inc. (NASDAQ:SRTS) Q3 2021 Earnings Conference Call November 4, 2021 4:30 PM ET Company Participants Kim Sutton Golodetz - Investor Relations, LHA Joseph Sardano - Chief Executive Officer Javier Rampolla - Chief Financial Officer Conference Call Participants Connor Stevenson - Craig-Hallum Capital Group Anthony Vendetti - Maxim Group, LLC Benjamin Haynor - Alliance Global Partners Yi Chen - H.C. Wainwright & Co. James Terwilliger - Northland Securities, Inc. Operator Ladies and gentlemen, ...
Sensus Healthcare(SRTS) - 2021 Q2 - Quarterly Report
2021-08-13 14:09
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ____________ to ____________ Commission File Number: 001-37714 Sensus Healthcare, Inc. (Exact name of registrant as specified in its charter) | Delaware | 27-1647271 | | ...
Sensus Healthcare(SRTS) - 2021 Q2 - Earnings Call Transcript
2021-08-08 14:31
Sensus Healthcare, Inc. (NASDAQ:SRTS) Q2 2021 Earnings Conference Call August 5, 2021 4:30 PM ET Company Participants Kim Golodetz - Investor Relations, LHA Joe Sardano - Chief Executive Officer Javier Rampolla - Chief Financial Officer Conference Call Participants Anthony Vendetti - Maxim Group Ben Haynor - Alliance Global Partners Yi Chen - H.C. Wainwright James Terwilliger - Northland Securities Operator Good day, ladies and gentlemen. And welcome to the Sensus Healthcare Second Quarter 2021 Financial Re ...
Sensus Healthcare(SRTS) - 2021 Q1 - Quarterly Report
2021-05-14 16:19
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ____________ to ____________ Commission File Number: 001-37714 Sensus Healthcare, Inc. (Exact name of registrant as specified in its charter) | Delaware | 27-1647271 | | ...
Sensus Healthcare(SRTS) - 2020 Q4 - Earnings Call Transcript
2021-05-09 05:55
Sensus Healthcare, Inc. (NASDAQ:SRTS) Q1 2021 Earnings Conference Call May 6, 2021 4:30 PM ET Company Participants Kim Golodetz - Investor Relations Joe Sardano - Chief Executive Officer Javier Rampolla - Chief Financial Officer Conference Call Participants Yi Chen - H.C. Wainwright. Anthony Vendetti - Maxim Group Operator Good day, ladies and gentlemen and welcome to the Sensus Healthcare First Quarter 2021 Financial Results Conference Call. All lines have been placed on a listen-only mode and the floor wi ...
Sensus Healthcare(SRTS) - 2020 Q4 - Annual Report
2021-03-05 17:58
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE FISCAL YEAR ENDED DECEMBER 31, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM ____________ TO ____________ Sensus Healthcare, Inc. (Exact name of registrant as specified in its charter) Delaware 27-1647271 (State or other jurisdiction of incorporation ...
Sensus Healthcare(SRTS) - 2020 Q3 - Quarterly Report
2020-11-10 18:44
FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended September 30, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ____________ to ____________ Commission File Number: 001-37714 Sensus Healthcare, Inc. (Exact name of registrant as specified in its charter) | Delaware | 27-1647271 ...